Showing results (51-60 of 68) with videos related to
Sort By:
Pageof 7
JCSM Communications|July 14, 2025
Intramuscular CMT-167 Tumors Produce a Mild Cachexia Phenotype in C57BL/6J MiceBryan C Remaily, Trang T Vu, Justin Thomas, et al.Plos One|July 20, 2016
Preclinical Evaluation of the Novel BTK Inhibitor Acalabrutinib in Canine Models of B-Cell Non-Hodgkin LymphomaBonnie K Harrington, Heather L Gardner, Raquel Izumi, et al.Cancers|February 27, 2026
A Novel Mouse Model to Identify Antigen-Specific Immune Responses in Pancreatic Cancer CachexiaAyushi Das, Debasmita Mukherjee, Liliana D'Alesio, et al.JCSM Rapid Communications|September 13, 2021
Murine cancer cachexia models replicate elevated catabolic pembrolizumab clearance in humansAlyssa Marie M Castillo, Trang T Vu, Sophia G Liva, et al.Biorxiv : the Preprint Server for Biology|November 24, 2025
Androgens Drive SOX9 Upregulation in Injured Proximal Tubular CellsCorynne Vermillion Allison, Prisha S Patel, Qiao Xuanyuan, et al.Frontiers in Immunology|April 16, 2026
Fc gamma receptor binding modulates IgG clearance in cancer cachexiaBryan C Remaily, Kyeongmin Kim, Justin Thomas, et al.Pharmacological Research|December 25, 2023
Decoupling FcRn and tumor contributions to elevated immune checkpoint inhibitor clearance in cancer cachexiaTrang T Vu, Kyeongmin Kim, Millennium Manna, et al.International Immunopharmacology|May 8, 2026
FcRn function alone cannot account for elevated IgG clearance in the Lewis lung carcinoma model of cancer cachexiaAdeoluwa Adeluola, Justin Thomas, Bryan Remaily, et al.International Journal of Molecular Sciences|July 9, 2022
The Neonatal Fc Receptor Is Elevated in Monocyte-Derived Immune Cells in Pancreatic CancerJustin Thomas, Molly A Torok, Kriti Agrawal, et al.Journal of Natural Products|February 25, 2022
Discovery of Anticancer Agents of Diverse Natural OriginLeslie N Aldrich, Joanna E Burdette, Esperanza Carcache de Blanco, et al.Pageof 7